1. Home
  2. /
  3. Availability
  4. /
  5. New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

Description

We estimated the potential health and economic impact of M72/AS01E and BCG-revaccination in India and investigated the impact of variation in vaccine characteristics and delivery strategies.
TB vaccine theme
Availability
Economic impact/cost-effectivenss, Epidemiological impact

Project details

Country
India
Timeline
2023
Target group
Adolescents, General Adults
Vaccine
BCG revaccination, M72/AS01e
Type of protection of vaccine
Prevention of disease, Prevention of infection
Type of research
Modelling
Partners involved
BMGF, Government of India, Harvard University, KNCV, LSHTM, Sanofi Pasteur, WHO
Type of project
research

Resources

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

Contact

Joeri Buis
joeri.buis@kncvtbc.org
Click to copy link of this headerMenu